nucleoside analogs (Novadex Pharmaceuticals AB)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug Namenucleoside analogs (Novadex Pharmaceuticals AB)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNucleotide reverse transcriptase inhibitors
TargetsNucleotide reverse transcriptase
Therapy Area/IndicationsHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNovadex Pharmaceuticals AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNovadex Pharmaceuticals AB
Active IndicationsN/A
Inactive IndicationsHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A